Jobst Technologies
small smart solutions

news

Jobst Technologies Joins Horizon Europe’s ARMADILLO Project

Published 9. October 2025

Freiburg, Ger­many – Octo­ber 2024

Job­st Tech­nolo­gies is a key part­ner in the EU-fund­ed ARMADILLO project, which aims to devel­op portable, rapid foren­sic tools for detect­ing Gam­ma-Hydrox­y­bu­tyrate (GHB) in bod­i­ly flu­ids and bev­er­ages. Lever­ag­ing its exper­tise in biosen­sors and microflu­idics, Job­st is con­tribut­ing to the cre­ation of field-ready devices to sup­port law enforce­ment in inves­ti­gat­ing drug-facil­i­tat­ed crimes. Empha­sis­ing eth­i­cal com­pli­ance and tech­no­log­i­cal inno­va­tion, the project is run­ning until 2027, with pilot pro­grammes already under­way in Europe.

For more infor­ma­tion, vis­it armadillo-project.eu

Ebnet Medical at Jobst Technologies

Published 2. July 2025

Last week Jens Ebnet from Ebnet Med­ical vis­it­ed us to form a joint vision for the future of meta­bol­ic mon­i­tor­ing and safe, reli­able venous access* for hos­pi­tal­ized patients.

We believe that bring­ing Glu­cose and Lac­tate mon­i­tor­ing clos­er to patients and com­bin­ing it with much need­ed next-gen­er­a­tion vas­cu­lar access devices has the poten­tial to save more lives in sit­u­a­tions where every missed sec­ond in patient care endan­gers inter­ven­tion success.

What inno­va­tions are dire­ly need­ed in crit­i­cal and acute care?
Vis­it us and dic­suss at the IVAM HIGH-TECH FORUM area in Hall 8a at Med­ica / Com­pamed fair 2025.

*cur­rent­ly under development

 

 

TERMIS 2025

Published 2. June 2025

In May 2025 we exhib­it­ed at TERMIS 2025 in our home­town Freiburg, Germany!

This engag­ing event brought togeth­er the tis­sue engi­neer­ing and regen­er­a­tive med­i­cine com­mu­ni­ty from Uni­ver­si­ties, R&D groups and com­mer­cial Play­ers worldwide!

Thanks to the vast num­ber of Posters, impres­sive amount of sci­en­tif­ic pan­els and inter­ac­tions at our booth we were grate­ful to get even more insights in cur­rent and future ther­a­pies and offer­ings in this much need­ed and rel­e­vant field!

We are look­ing back on inter­est­ing and thought-inspir­ing dis­cus­sions on our booth with vis­i­tors who are inves­ti­gat­ing the meta­bol­ic behav­ior and reac­tion of the cells in scaf­folds, organoids, 2D, 3D and sus­pen­sion cul­tures of their in-vit­ro models!

Vis­it our Con­tact page to get in touch with us for con­tin­u­ous Biosen­sors for meta­bol­ic mon­i­tor­ing in micro­phys­i­o­log­i­cal sys­tems (MPS).

CGT 4.0 Opinion Paper published in Frontiers in Bioengineering and Biotechnology

Published 25. April 2025

Will cell and gene ther­a­py (CGT) man­u­fac­tur­ing inevitably move to small batch and sin­gle dose pro­duc­tion?
How can we ensure sus­tain­able man­u­fac­tur­ing and make these life-sav­ing ther­a­pies avail­able for more patients in need?

Togeth­er with our part­ners from Lim­u­la, Tech­nis­che Uni­ver­sität Wien, Stem­mat­ters, Exothera from the PAT4CGT Project con­sor­tium here is our stance on this top­ic up for dis­cus­sion in the opin­ion paper:
CGT 4.0: a dis­tant dream or inevitable future? Smart process automa­tion is crit­i­cal to make effi­cient scal­a­bil­i­ty of CGT man­u­fac­tur­ing a reality

DOI: 10.3389/fbioe.2025.1563878

Vis­it our Con­tact Page to inquire abou how we can con­tribute to your CGT and Advanced Ther­a­pies pro­duc­tion and ana­lyzis equipment!

Compamed 2024 — High-tech solutions for medical technology

Published 8. November 2024

Meet us in Düs­sel­dorf at Com­pamed 2024.

Togeth­er with Inno­v­a­tive Sen­sor Tech­nol­o­gy IST AG and Sen­stech AG, Job­st Tech­nolo­gies will be exhibit­ing at this years COMPAMED in Düsseldorf.

We will wel­come you in Hall 8a H29‑1 at our booth.

Com­pamed 2024, 11. — 14. Novem­ber 2024

Live pre­sen­ta­tion and Q&A:

Con­tin­u­ous Biosen­sors in Crit­i­cal Care Appli­ca­tions: Lac­tate, Glu­cose and Beyond

Mon­day the 11th of Novem­ber from 1:50 pm to 2:10 pm
at the COMPAMED HIGH-TECH FORUM by IVAM, Hall 8a, Both 8a G40

 

1 2 3 … 8